Multiplex User Group Event 2024

​​​​​​For the first time, we are happy to announce that we are hosting the Multiplex User Group Event in Australia, to be held in Brisbane, Sydney and Melbourne.  

Brisbane – Monday 20th May, 3pm-7pm
Sydney – Wednesday 22nd May, 3pm-7pm
Melbourne – Friday 24th May, 3pm-7pm –  SOLD OUT

About the Event:
This event aims to provide our scientific community, and Multiplex technology users the opportunity to network and be in front of the cutting-edge technology that our suppliers, Luminex and Merck, are releasing within this space.​​​​​​

Event Inclusions:

  • Free to attend
  • Welcome gift
  • Light dinner and refreshments
  • Research and travel grants for poster and presentation winners!

Register below:

         ​

View Updated Program Here →


Speaker
Stephen Angeloni
Sr. Field Application Scientist, Luminex Corporation, US.

Presentation title: 
Precision coupling to develop multiplex xMAP assays for a variety of applications.​​​​​​

  ​​​​​​

​​​​Biography: 
Dr. Angeloni received his PhD in Biochemistry from Virginia Polytechnic Inst. and State University. Before joining Luminex he had over 30 years of research and industry experience in developing biochemical, genetic, proteomic, immunology, microscopy, cellular, molecular biology assays and bioinformatic tools.  These technologies were applied to studying the mechanisms and treatments of diseases such as cancer, obesity, diabetes, and the development of DNA vaccines. In his 12 years with Luminex, he has successfully supported the development of high-profile genomic and proteomic assays for research and diagnostics).​​​​​​


Speaker
Naveen Kumar Nandan
Senior Technical & Product Marketing Manager at Merck

Presentation title: 
Exploring the Boundless Horizons of Milliplex(R) from Merck & Deciphering 
Immunological Landscapes “Scientific Insights on Applications, Scope and
Beyond”

  ​​​​​​

​​​​Biography: 
With an extensive career spanning over 18 years across diverse sectors including academia, industry, hospitals, and diagnostics, Naveen brings a wealth of experience and expertise to the field of life sciences. With a specialization in Protein Biology in his higher studies, Naveen and has further enhanced his qualifications with an MBA from XLRI, a combination that seamlessly integrates scientific proficiency with keen business acumen. His professional journey includes roles as a research associate within Biotechnology and Contract Research Organization laboratories, where he has made contributions & Publications in Cervical Cancer and metabolism research. Currently, Naveen is focused on supporting state-of-the-art technologies in Protein & Pathway Analysis specifically tailored for the Asia-Pacific region,


Speaker

Carmel Taylor
Supervising Scientist, Diagnostic Serology, Public Health Virology
at Queensland Health

Presentation title: 
Microsphere immunoassays for detection and differentiation of viral antibodies

  ​​​​​​

​​​​Biography: 
Carmel brings over 30 years of diagnostic serology expertise to her role as Supervising Scientist (Serology) at Forensic and Scientific Services’ Public Health Virology laboratory at Queensland Health. Her leadership is pivotal in developing advanced serological assays (microsphere immunoassays) for diagnosing viral diseases that pose significant threats to public health in Queensland. Her wealth of knowledge, commitment and dedication to innovation have earned her widespread respect as a driving force behind the advancement of diagnostic capabilities and protection of population health.


Speaker

Ramin Mazhari
Senior Research Scientist; Population, Health and Immunity Division; 
Walter and Eliza Hall Institute of Medical Research

Presentation title: 
Development of a serological assay to identify “undetectable”
malaria infections, using coupled microspheres.

 

​​​​​​

​​​​Biography: 

After completing his PhD in Marburg, Germany in molecular parasitology, Ramin took up a post-doctoral position in the field of malaria at the Walter and Eliza Hall Institute of Medical Research in Melbourne. He has made significant contributions to the development of a serological assay to predict the presence of hidden liver stages of Plasmodium vivax (a human malaria species), in order to improve malaria eradication efforts.

In addition, he has been instrumental in teaching and transferring this technique to other laboratories in Southeast Asia and Africa.


Final Abstract Submissions

Brisbane Submissions – Abstract Title First Author
Serosurveillance for tropical diseases Palakorn Chintanawiwat
A functional PSA prostate cancer susceptibility genetic variant confers both reduced and aggressive cancer risk Jyotsna Batra

 

Sydney Submissions – Abstract Title First Author
MDMDM2 inhibition is potent against ER-positive breast cancer in a dual endocrine therapy and CDK4/6 inhibitor-resistant setting. Fiona Zhou
Maternal immune activation and estrogen receptor modulation promote sex-specific alterations in inflammatory-related molecules in the rat substantia nigra Sophie Debs
Multiplexing cytokines assay demonstrates distinct inflammatory responses to the microbial endotoxin in intestinal organoids. Chenkai Ma
Development of a Plasma Biomarker Panel for Vascular Cognitive Impairment through Multiplex Assay Technology Tharusha Jayasena
TBC Mirei Okada

 

Melbourne Submissions – Abstract Title First Author
Lactate Dehydrogenase antigen detection tool for symptomatic and cryptic infections of Plasmodium vivax Anju Abraham
Induction of SARS-CoV-2-specific dimeric IgA antibodies post COVID-19 vaccination Nick Walker
Long-lived anti-cytokine autoantibodies associated with post-COVID-19 sequalae Catherine Chen
Development of a Plasma Biomarker Panel for Vascular Cognitive Impairment through Multiplex Assay Technology Tharusha Jayasena
Effect of suboptimal standard curves in a multiplex serological assay on ML classification performance Joshua Yong
Investigating role of immunity to Plasmodium falciparum antigens other than VAR2CSA in protection from placental malaria- A Systems Serology approach Yvonne Dube
Systems serology identifies novel autoantibody signatures for Sjögren’s syndrome diagnosis. Amy Chung
Plasmodium vivax serological exposure markers to uncover hidden malaria infections Rhea Longley
Sooner or later? Impact of COVID-19 booster intervals on mucosal antibody responses Kevin John
Investigating Psychoneuroimmunological Responses to the Influenza Vaccine: Towards a Deployable Human Integrated Sensor System Juliana Bajic



Request a Quote

Request Quote

Top